首页 > 最新文献

Future Science OA最新文献

英文 中文
Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population.
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2024-12-06 DOI: 10.1080/20565623.2024.2432222
Dalia Ghalwash, Ahmed Ammar, Asmaa Abou-Bakr, Al-Hassan Diab, Ayman El-Gawish

Purpose: The present study evaluated the sensitivity and specificity of important proteomic salivary biomarkers; IL-6, IL-8, and sCD44 in the early detection of oral cancer, and any possible associations with risk factors of oral cancer in an Egyptian population.

Methods: The present investigation was conducted on 100 individuals; 25 healthy controls, 25 patients having oral potentially malignant disorders (OPMDs) with dysplasia; 25 patients having OPMDs without dysplasia, and 25 oral cancer patients. Demographic data modified gingival index, oral hygiene level, and salivary levels of the biomarkers were assessed.

Results: Salivary levels of IL-6, IL-8, and sCD44 progressively increased with increased disease severity. Salivary IL-8 and IL-6 levels possess a discriminating potential from normal tissue through different degrees of dysplasia to oral cancer, sCD44 levels had a discriminating power between normal and dysplastic tissues with high sensitivity and specificity. A positive correlation was found between the three biomarkers and the grade of oral squamous cell carcinoma (OSCC) and with different risk factors.

Conclusion: This is the first study that evaluated multiple salivary proteomic biomarkers in the Egyptian population, and the results validate the ability of IL-6, IL-8, and sCD44 to be used as sensitive diagnostic and prognostic biomarkers for screening and early detection of oral cancer.

{"title":"Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population.","authors":"Dalia Ghalwash, Ahmed Ammar, Asmaa Abou-Bakr, Al-Hassan Diab, Ayman El-Gawish","doi":"10.1080/20565623.2024.2432222","DOIUrl":"10.1080/20565623.2024.2432222","url":null,"abstract":"<p><strong>Purpose: </strong>The present study evaluated the sensitivity and specificity of important proteomic salivary biomarkers; IL-6, IL-8, and sCD44 in the early detection of oral cancer, and any possible associations with risk factors of oral cancer in an Egyptian population.</p><p><strong>Methods: </strong>The present investigation was conducted on 100 individuals; 25 healthy controls, 25 patients having oral potentially malignant disorders (OPMDs) with dysplasia; 25 patients having OPMDs without dysplasia, and 25 oral cancer patients. Demographic data modified gingival index, oral hygiene level, and salivary levels of the biomarkers were assessed.</p><p><strong>Results: </strong>Salivary levels of IL-6, IL-8, and sCD44 progressively increased with increased disease severity. Salivary IL-8 and IL-6 levels possess a discriminating potential from normal tissue through different degrees of dysplasia to oral cancer, sCD44 levels had a discriminating power between normal and dysplastic tissues with high sensitivity and specificity. A positive correlation was found between the three biomarkers and the grade of oral squamous cell carcinoma (OSCC) and with different risk factors.</p><p><strong>Conclusion: </strong>This is the first study that evaluated multiple salivary proteomic biomarkers in the Egyptian population, and the results validate the ability of IL-6, IL-8, and sCD44 to be used as sensitive diagnostic and prognostic biomarkers for screening and early detection of oral cancer.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2432222"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: lichen planus in a patient with ulcerative colitis receiving sulfasalazine: a drug effect or a disease manifestation?
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2024-12-05 DOI: 10.1080/20565623.2024.2432240
Ahmed Mohamed Nefzi, Haythem Yacoub, Asmahane Souissi, Hajer Hassine, Dhouha Cherif, Habiba Debbabi, Héla Kchir, Nadia Maamouri

Lichen Planus is an inflammatory skin disease that has been reported to be associated with inflammatory diseases like Inflammatory Bowel Disease or with medication use such as sulfasalazine. We report a case of lichen planus in a 62-year-old patient with ulcerative colitis receiving sulfasalazine. Within three years of treatment, the patient developed an erythematous rash on her forehead and wrists, which gradually worsened and spread to her arms, forearms, neck, and upper back. Lichen planus was suspected and later confirmed through histopathological examination. Consequently, sulfasalazine was discontinued, leading to partial resolution of the skin lesions. Our case highlights the importance of a thorough patient interview, as the timeline of skin lesions in relation to medication use and disease activity.

{"title":"Case report: lichen planus in a patient with ulcerative colitis receiving sulfasalazine: a drug effect or a disease manifestation?","authors":"Ahmed Mohamed Nefzi, Haythem Yacoub, Asmahane Souissi, Hajer Hassine, Dhouha Cherif, Habiba Debbabi, Héla Kchir, Nadia Maamouri","doi":"10.1080/20565623.2024.2432240","DOIUrl":"10.1080/20565623.2024.2432240","url":null,"abstract":"<p><p>Lichen Planus is an inflammatory skin disease that has been reported to be associated with inflammatory diseases like Inflammatory Bowel Disease or with medication use such as sulfasalazine. We report a case of lichen planus in a 62-year-old patient with ulcerative colitis receiving sulfasalazine. Within three years of treatment, the patient developed an erythematous rash on her forehead and wrists, which gradually worsened and spread to her arms, forearms, neck, and upper back. Lichen planus was suspected and later confirmed through histopathological examination. Consequently, sulfasalazine was discontinued, leading to partial resolution of the skin lesions. Our case highlights the importance of a thorough patient interview, as the timeline of skin lesions in relation to medication use and disease activity.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2432240"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142779860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers of mature neuronal differentiation and related diseases. 成熟神经元分化及相关疾病的生物标志物
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-10-21 DOI: 10.1080/20565623.2024.2410146
Xiaodong Yuan, Wen Li, Qi Yan, Ya Ou, Qingxi Long, Pingshu Zhang

The nervous system regulates perception, cognition and behavioral responses by serving as the body's primary communication system for receiving, regulating and transmitting information. Neurons are the fundamental structures and units of the nervous system. Their differentiation and maturation processes rely on the expression of specific biomarkers. Neuron-specific intracellular markers can be used to determine the degree of neuronal maturation. Neuronal cytoskeletal proteins dictate the shape and structure of neurons, while synaptic plasticity and signaling processes are intricately associated with neuronal synaptic markers. Furthermore, abnormal expression levels of biomarkers can serve as diagnostic indicators for nervous system diseases. This article reviews the markers of mature neuronal differentiation and their relationship with nervous system diseases.

神经系统作为人体接收、调节和传递信息的主要通信系统,调节感知、认知和行为反应。神经元是神经系统的基本结构和单位。它们的分化和成熟过程依赖于特定生物标记物的表达。神经元特异性细胞内标志物可用于确定神经元的成熟程度。神经元细胞骨架蛋白决定了神经元的形状和结构,而突触可塑性和信号传导过程则与神经元突触标记物密切相关。此外,生物标记物的异常表达水平可作为神经系统疾病的诊断指标。本文综述了成熟神经元分化标志物及其与神经系统疾病的关系。
{"title":"Biomarkers of mature neuronal differentiation and related diseases.","authors":"Xiaodong Yuan, Wen Li, Qi Yan, Ya Ou, Qingxi Long, Pingshu Zhang","doi":"10.1080/20565623.2024.2410146","DOIUrl":"10.1080/20565623.2024.2410146","url":null,"abstract":"<p><p>The nervous system regulates perception, cognition and behavioral responses by serving as the body's primary communication system for receiving, regulating and transmitting information. Neurons are the fundamental structures and units of the nervous system. Their differentiation and maturation processes rely on the expression of specific biomarkers. Neuron-specific intracellular markers can be used to determine the degree of neuronal maturation. Neuronal cytoskeletal proteins dictate the shape and structure of neurons, while synaptic plasticity and signaling processes are intricately associated with neuronal synaptic markers. Furthermore, abnormal expression levels of biomarkers can serve as diagnostic indicators for nervous system diseases. This article reviews the markers of mature neuronal differentiation and their relationship with nervous system diseases.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2410146"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver biopsy revealing anti-neutrophil cytoplasmic antibody-associated vasculitis: a tale for a challenging diagnosis. 肝活检发现抗中性粒细胞胞浆抗体相关性血管炎:一个具有挑战性诊断的故事。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-08-07 DOI: 10.2144/fsoa-2023-0222
Bahaeddine Lahbacha, Abir Chaabane, Wafa Garbouj, Roua Mankai, Amina Bani, Amal Khsiba, Raja Amri, Salwa Nechi, Emna Chelbi

A 62-year-old woman presented with a chronic fever and fatigue. Biological investigations showed leukocytosis and elevation of acute phase markers. Liver blood tests showed deterioration with both cholestatic and hepatocellular patterns (there were, respectively, elevations in serum alkaline phosphatase levels as well as in serum alanine and aspartate aminotransferases). Viral serologies were negative. Mycobacterial infection and endocarditis were excluded. Results from blood cultures were negative. Autoantibody tests including ANCA (anti-neutrophil cytoplasmic antibody), anti-nuclear, anti-smooth muscle and anti-mitochondria were all negative. A liver biopsy revealed epithelioid granulomatous necrotizing vasculitis. Subsequently, immunological testing was repeated revealing MPO-ANCA (myeloperoxidase-ANCA). A diagnosis of ANCA-associated vasculitis with liver involvement was then made. The patient was started on steroids and her clinical state gradually improved.

一名 62 岁的妇女因长期发烧和疲劳而就诊。生物检查显示白细胞增多,急性期标志物升高。肝脏血液检查显示病情恶化,有胆汁淤积性和肝细胞性两种模式(血清碱性磷酸酶水平以及血清丙氨酸和天冬氨酸转氨酶分别升高)。病毒血清学检测呈阴性。排除了分枝杆菌感染和心内膜炎。血液培养结果为阴性。包括抗中性粒细胞胞浆抗体(ANCA)、抗核抗体、抗平滑肌抗体和抗线粒体抗体在内的自身抗体检测结果均为阴性。肝脏活检显示患者患有上皮样肉芽肿坏死性血管炎。随后,再次进行免疫学检测,发现 MPO-ANCA(髓过氧化物酶-ANCA)。诊断结果为 ANCA 相关性血管炎并累及肝脏。患者开始服用类固醇,临床症状逐渐好转。
{"title":"Liver biopsy revealing anti-neutrophil cytoplasmic antibody-associated vasculitis: a tale for a challenging diagnosis.","authors":"Bahaeddine Lahbacha, Abir Chaabane, Wafa Garbouj, Roua Mankai, Amina Bani, Amal Khsiba, Raja Amri, Salwa Nechi, Emna Chelbi","doi":"10.2144/fsoa-2023-0222","DOIUrl":"10.2144/fsoa-2023-0222","url":null,"abstract":"<p><p>A 62-year-old woman presented with a chronic fever and fatigue. Biological investigations showed leukocytosis and elevation of acute phase markers. Liver blood tests showed deterioration with both cholestatic and hepatocellular patterns (there were, respectively, elevations in serum alkaline phosphatase levels as well as in serum alanine and aspartate aminotransferases). Viral serologies were negative. Mycobacterial infection and endocarditis were excluded. Results from blood cultures were negative. Autoantibody tests including ANCA (anti-neutrophil cytoplasmic antibody), anti-nuclear, anti-smooth muscle and anti-mitochondria were all negative. A liver biopsy revealed epithelioid granulomatous necrotizing vasculitis. Subsequently, immunological testing was repeated revealing MPO-ANCA (myeloperoxidase-ANCA). A diagnosis of ANCA-associated vasculitis with liver involvement was then made. The patient was started on steroids and her clinical state gradually improved.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2340262"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokine release syndrome caused by immune checkpoint inhibitors: a case report and literature review. 免疫检查点抑制剂引起的细胞因子释放综合征:病例报告和文献综述。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-11-22 DOI: 10.1080/20565623.2024.2422786
Xiuping Zhang, Yang You, Pengfei Zhang, Yan Wang, Feng Shen

Immune checkpoint inhibitors (ICIs) have gained widespread application in the treatment of malignant tumors. Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by various factors, including infections and immunotherapy. We present a case of CRS occurring in a gastric cancer patient after receiving combination therapy of tislelizumab, anlotinib and combination of capecitabine and oxaliplatin. Nineteen days after the third dose of tislelizumab, the patient experienced sudden unconsciousness, frothing at the mouth, convulsions and other clinical manifestations resembling epileptiform seizures. Elevated inflammatory markers, cytokine levels and ferritin were markedly increased. Given the absence of definite clinical evidence for metastasis and infection, the diagnosis of CRS was considered. Subsequent management with glucocorticoids and intravenous immunoglobulin resulted in the patient's improvement. However, antitumor therapy was halted, ultimately leading to death. The administration of ICIs can incite CRS, a severe, rapidly progressing condition with a poor prognosis, demanding clinical attention. Cytokines play a dual role in the pathophysiology of immune-related adverse events by mediating self-tolerance attenuation and enhancing the activation of cytotoxic T cells in the antitumor process of ICIs. The therapy of glucocorticoids combined with cytokine inhibitors may become an effective remedy.

免疫检查点抑制剂(ICIs)已广泛应用于恶性肿瘤的治疗。细胞因子释放综合征(CRS)是由感染和免疫治疗等多种因素引发的全身炎症反应。我们报告了一例胃癌患者在接受替斯利珠单抗、安罗替尼以及卡培他滨和奥沙利铂联合治疗后发生 CRS 的病例。在服用第三剂替斯利珠单抗19天后,患者突然出现昏迷、口吐白沫、抽搐和其他类似癫痫样发作的临床表现。炎症指标、细胞因子水平和铁蛋白明显升高。鉴于没有明确的转移和感染的临床证据,考虑诊断为 CRS。随后使用糖皮质激素和静脉注射免疫球蛋白进行治疗,患者病情有所好转。然而,抗肿瘤治疗却停止了,最终导致患者死亡。使用 ICIs 可诱发 CRS,这是一种严重、进展迅速、预后不良的疾病,需要引起临床重视。细胞因子在免疫相关不良事件的病理生理学中扮演着双重角色,它们在 ICIs 的抗肿瘤过程中介导自身耐受衰减和增强细胞毒性 T 细胞的活化。糖皮质激素联合细胞因子抑制剂的疗法可能是一种有效的补救措施。
{"title":"Cytokine release syndrome caused by immune checkpoint inhibitors: a case report and literature review.","authors":"Xiuping Zhang, Yang You, Pengfei Zhang, Yan Wang, Feng Shen","doi":"10.1080/20565623.2024.2422786","DOIUrl":"10.1080/20565623.2024.2422786","url":null,"abstract":"<p><p>Immune checkpoint inhibitors (ICIs) have gained widespread application in the treatment of malignant tumors. Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by various factors, including infections and immunotherapy. We present a case of CRS occurring in a gastric cancer patient after receiving combination therapy of tislelizumab, anlotinib and combination of capecitabine and oxaliplatin. Nineteen days after the third dose of tislelizumab, the patient experienced sudden unconsciousness, frothing at the mouth, convulsions and other clinical manifestations resembling epileptiform seizures. Elevated inflammatory markers, cytokine levels and ferritin were markedly increased. Given the absence of definite clinical evidence for metastasis and infection, the diagnosis of CRS was considered. Subsequent management with glucocorticoids and intravenous immunoglobulin resulted in the patient's improvement. However, antitumor therapy was halted, ultimately leading to death. The administration of ICIs can incite CRS, a severe, rapidly progressing condition with a poor prognosis, demanding clinical attention. Cytokines play a dual role in the pathophysiology of immune-related adverse events by mediating self-tolerance attenuation and enhancing the activation of cytotoxic T cells in the antitumor process of ICIs. The therapy of glucocorticoids combined with cytokine inhibitors may become an effective remedy.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2422786"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587866/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imperative role of adaptor proteins in macrophage toll-like receptor signaling pathways. 适配蛋白在巨噬细胞收费样受体信号通路中的重要作用
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-09-09 DOI: 10.1080/20565623.2024.2387961
Aurelia Rughetti, Shreya Bharti, Rajkumar Savai, Spyridoula Barmpoutsi, Andreas Weigert, Rajat Atre, Faaiza Siddiqi, Rahul Sharma, Rakhi Khabiya, Nik Hirani, Mirza S Baig

Macrophages are integral part of the body's defense against pathogens and serve as vital regulators of inflammation. Adaptor molecules, featuring diverse domains, intricately orchestrate the recruitment and transmission of inflammatory responses through signaling cascades. Key domains involved in macrophage polarization include Toll-like receptors (TLRs), Src Homology2 (SH2) and other small domains, alongside receptor tyrosine kinases, crucial for pathway activation. This review aims to elucidate the enigmatic role of macrophage adaptor molecules in modulating macrophage activation, emphasizing their diverse roles and potential therapeutic and investigative avenues for further exploration.

巨噬细胞是人体抵御病原体的重要组成部分,也是炎症的重要调节因子。具有不同结构域的适配分子通过信号级联错综复杂地协调着炎症反应的招募和传递。参与巨噬细胞极化的关键结构域包括Toll样受体(TLRs)、Src Homology2(SH2)和其他小结构域,以及对通路激活至关重要的受体酪氨酸激酶。本综述旨在阐明巨噬细胞适配体分子在调节巨噬细胞活化中的神秘作用,强调它们的不同作用以及有待进一步探索的潜在治疗和研究途径。
{"title":"Imperative role of adaptor proteins in macrophage toll-like receptor signaling pathways.","authors":"Aurelia Rughetti, Shreya Bharti, Rajkumar Savai, Spyridoula Barmpoutsi, Andreas Weigert, Rajat Atre, Faaiza Siddiqi, Rahul Sharma, Rakhi Khabiya, Nik Hirani, Mirza S Baig","doi":"10.1080/20565623.2024.2387961","DOIUrl":"10.1080/20565623.2024.2387961","url":null,"abstract":"<p><p>Macrophages are integral part of the body's defense against pathogens and serve as vital regulators of inflammation. Adaptor molecules, featuring diverse domains, intricately orchestrate the recruitment and transmission of inflammatory responses through signaling cascades. Key domains involved in macrophage polarization include Toll-like receptors (TLRs), Src Homology2 (SH2) and other small domains, alongside receptor tyrosine kinases, crucial for pathway activation. This review aims to elucidate the enigmatic role of macrophage adaptor molecules in modulating macrophage activation, emphasizing their diverse roles and potential therapeutic and investigative avenues for further exploration.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2387961"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11385170/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of hematologic cancer types in Japan by ICD-O-3 code: analysis of National Cancer Registry. 按 ICD-O-3 编码划分的日本血液肿瘤类型发病率:全国癌症登记处分析。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-10-17 DOI: 10.1080/20565623.2024.2413801
Ayako Muramatsu, Tetsuji Kawakami

Aim: We classified subtypes of hematologic cancer in Japan's National Cancer Registry (NCR) in 2016 by ICD-O-3 code and compared numbers with the Japanese Society of Hematology's Blood Diseases Registry (BDR).Materials & methods: We reviewed data for individual cases, and calculated incidence per 100,000.Results: NCR reported 67,919 cases of hematological cancer, including diffuse large B-cell lymphoma, Not Otherwise Specified (NOS) (11.07 per 100,000), plasma cell myeloma (5.26/100,000), myelodysplastic syndrome, NOS (3.92/100,000), malignant lymphoma, NOS (3.03/100,000), marginal zone B-cell lymphoma, NOS (2.52/100,000) and follicular lymphoma, grade 1 (1.43/100,000). Around 48% of NCR cancers were also reported in the Blood Diseases Registry.Conclusion: ICD-O-3 codes revealed 12,365 additional cases to the 55,554 reported publicly. Accurately updated data are necessary for medical resource planning.

目的:我们根据ICD-O-3代码对2016年日本国家癌症登记处(NCR)的血液肿瘤亚型进行了分类,并与日本血液学会的血液疾病登记处(BDR)的数字进行了比较:我们审查了单个病例的数据,并计算了每十万人的发病率:NCR报告了67919例血液肿瘤病例,包括弥漫大B细胞淋巴瘤、未另作说明的淋巴瘤(NOS)(11.07/100,000)、浆细胞骨髓瘤(5.26/100,000)、骨髓增生异常综合征(NOS)(3.92/100,000)、恶性淋巴瘤(NOS)(3.03/100,000)、边缘区 B 细胞淋巴瘤(NOS)(2.52/100,000)和 1 级滤泡淋巴瘤(1.43/100,000)。约 48% 的 NCR 癌症在血液病登记处也有报告:结论:ICD-O-3 编码显示,在公开报告的 55554 个病例之外,又增加了 12365 个病例。医疗资源规划需要准确更新数据。
{"title":"Incidence of hematologic cancer types in Japan by ICD-O-3 code: analysis of National Cancer Registry.","authors":"Ayako Muramatsu, Tetsuji Kawakami","doi":"10.1080/20565623.2024.2413801","DOIUrl":"10.1080/20565623.2024.2413801","url":null,"abstract":"<p><p><b>Aim:</b> We classified subtypes of hematologic cancer in Japan's National Cancer Registry (NCR) in 2016 by ICD-O-3 code and compared numbers with the Japanese Society of Hematology's Blood Diseases Registry (BDR).<b>Materials & methods:</b> We reviewed data for individual cases, and calculated incidence per 100,000.<b>Results:</b> NCR reported 67,919 cases of hematological cancer, including diffuse large B-cell lymphoma, Not Otherwise Specified (NOS) (11.07 per 100,000), plasma cell myeloma (5.26/100,000), myelodysplastic syndrome, NOS (3.92/100,000), malignant lymphoma, NOS (3.03/100,000), marginal zone B-cell lymphoma, NOS (2.52/100,000) and follicular lymphoma, grade 1 (1.43/100,000). Around 48% of NCR cancers were also reported in the Blood Diseases Registry.<b>Conclusion:</b> ICD-O-3 codes revealed 12,365 additional cases to the 55,554 reported publicly. Accurately updated data are necessary for medical resource planning.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2413801"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19. 评估三唑韦林与奥司他韦在治疗 COVID-19 中的疗效。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-11-14 DOI: 10.1080/20565623.2024.2418798
Sara Samir Mohamed Elmenshawy, Mohamed Farouk Ahmed Abdelsalam, Tarek Refaat El Nagdy, Mohamed Abdel Salam Elgohary, Nagwa Ali Sabri, Amal El-Kholy

Aim: To compare the safety and efficacy of triazavirin (TZV) 250 mg capsules versus oseltamivir 75 mg capsules in the treatment of individuals diagnosed with COVID-19.Materials & methods: A double-blind, randomized, interventional pilot study was conducted in a parallel design with a 7-day treatment period.Results: The results showed that TZV is superior to oseltamivir regarding length of hospital stay, days until clinical symptoms improvement, and cure of chest pneumonia.Discussion: Different literature data indicate the superiority of TZV in treating COVID-19 when compared with other therapeutic agents. While there is controversy about the efficacy of oseltamivir.Conclusion: It was concluded that TZV is more effective than oseltamivir in the management of COVID-19 disease.Trial registration number: NCT04973462.

目的:比较三氮唑韦林(TZV)250 毫克胶囊与奥司他韦 75 毫克胶囊在治疗确诊的 COVID-19 患者中的安全性和有效性:采用平行设计进行了一项双盲、随机、干预性试验研究,治疗期为 7 天:结果表明,在住院时间、临床症状改善天数和胸部肺炎治愈率方面,TZV优于奥司他韦:讨论:不同的文献数据表明,与其他治疗药物相比,TZV 在治疗 COVID-19 方面更具优势。结论:结论:在治疗 COVID-19 疾病方面,TZV 比奥司他韦更有效:试验注册号:NCT04973462。
{"title":"Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19.","authors":"Sara Samir Mohamed Elmenshawy, Mohamed Farouk Ahmed Abdelsalam, Tarek Refaat El Nagdy, Mohamed Abdel Salam Elgohary, Nagwa Ali Sabri, Amal El-Kholy","doi":"10.1080/20565623.2024.2418798","DOIUrl":"10.1080/20565623.2024.2418798","url":null,"abstract":"<p><p><b>Aim:</b> To compare the safety and efficacy of triazavirin (TZV) 250 mg capsules versus oseltamivir 75 mg capsules in the treatment of individuals diagnosed with COVID-19.<b>Materials & methods:</b> A double-blind, randomized, interventional pilot study was conducted in a parallel design with a 7-day treatment period.<b>Results:</b> The results showed that TZV is superior to oseltamivir regarding length of hospital stay, days until clinical symptoms improvement, and cure of chest pneumonia.<b>Discussion:</b> Different literature data indicate the superiority of TZV in treating COVID-19 when compared with other therapeutic agents. While there is controversy about the efficacy of oseltamivir.<b>Conclusion:</b> It was concluded that TZV is more effective than oseltamivir in the management of COVID-19 disease.<b>Trial registration number:</b> NCT04973462.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2418798"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscope disinfectant-induced colonic pseudolipomatosis: case series of a rare condition. 内窥镜消毒剂诱发的结肠假脂瘤病:罕见病例系列。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-06-12 DOI: 10.2144/fsoa-2023-0210
Charfeddine Baccouche, Myriam Ayari, Imen Abdelaali, Amen Dhaoui, Taieb Jomni, Mohamed Hedi Douggui

Aim: Colonic mucosal pseudolipomatosis is a rare and benign endoscopic finding with distinct macroscopic and histological characteristics. Case series: We observed a form of unprecedented colitis in eight patients in a 3-month period. Operators have found, during colonoscopy, flat or slightly raised whitish-yellow plaques, in the colonic mucosa of all patients. Histological examination concluded to pseudolipomatosis. After investigation, the disinfectant machine was found to have technical malfunctioning of the rinse cycle of the endoscope during this period. No other cases were observed after the machine was fixed. Conclusion: Pseudolipomatosis is more an endoscopically induced lesion than a true pathological condition. A careful check of the disinfection process should be carried out when such lesions are detected.

目的:结肠粘膜假脂瘤病是一种罕见的良性内镜病变,具有明显的宏观和组织学特征。病例系列:我们在 3 个月内观察到 8 名患者出现了这种前所未有的结肠炎。操作人员在结肠镜检查中发现,所有患者的结肠粘膜上都有扁平或略微隆起的白黄色斑块。组织学检查的结论是假性脂肪瘤病。经调查发现,在此期间,消毒机的内窥镜冲洗循环出现了技术故障。机器修好后,未再发现其他病例。结论假性脂肪瘤是内窥镜诱发的病变,而非真正的病理状态。发现此类病变时,应仔细检查消毒过程。
{"title":"Endoscope disinfectant-induced colonic pseudolipomatosis: case series of a rare condition.","authors":"Charfeddine Baccouche, Myriam Ayari, Imen Abdelaali, Amen Dhaoui, Taieb Jomni, Mohamed Hedi Douggui","doi":"10.2144/fsoa-2023-0210","DOIUrl":"10.2144/fsoa-2023-0210","url":null,"abstract":"<p><p><b>Aim:</b> Colonic mucosal pseudolipomatosis is a rare and benign endoscopic finding with distinct macroscopic and histological characteristics. <b>Case series:</b> We observed a form of unprecedented colitis in eight patients in a 3-month period. Operators have found, during colonoscopy, flat or slightly raised whitish-yellow plaques, in the colonic mucosa of all patients. Histological examination concluded to pseudolipomatosis. After investigation, the disinfectant machine was found to have technical malfunctioning of the rinse cycle of the endoscope during this period. No other cases were observed after the machine was fixed. <b>Conclusion:</b> Pseudolipomatosis is more an endoscopically induced lesion than a true pathological condition. A careful check of the disinfection process should be carried out when such lesions are detected.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO985"},"PeriodicalIF":2.5,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11172253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis. 羧甲基铁治疗心力衰竭患者的铁缺乏症:系统综述和荟萃分析。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-31 Epub Date: 2024-07-09 DOI: 10.1080/20565623.2024.2367956
Burhanuddin Sohail Rangwala, Varisha Zuhair, Muhammad Saqlain Mustafa, Abdullah Mussarat, Aimen Waqar Khan, Fnu Danish, Syeda Mahrukh Fatima Zaidi, Faizan Ur Rehman, Muhammad Ashir Shafique

Aim: Iron deficiency (ID) is associated with heart failure (HF) in a considerable proportion of patients. To improve the quality of life, lower the frequency of hospitalizations, and lower mortality rates of chronic HF patients (HF), this meta-analysis will look into the role of iron supplementation using ferric carboxymaltose (FCM). Methods & results: From inception until 1 October 2023, we conducted a thorough literature search of electronic databases for peer-reviewed publications. Around 5229 HF patients were included, of which 2691 received FCM while 2538 received placebo. Conclusion: FCM reduces HF-related hospitalizations but doesn't improve overall or cardiovascular mortality in those with HF and ID. The overall results support FCM's role in managing iron deficiency in heart failure.

目的:相当一部分患者缺铁(ID)与心力衰竭(HF)有关。为了改善慢性心力衰竭(HF)患者的生活质量、降低住院频率和死亡率,本荟萃分析将研究使用羧甲基铁(FCM)补充铁的作用。方法与结果:从开始到 2023 年 10 月 1 日,我们在电子数据库中对同行评审过的出版物进行了全面的文献检索。共纳入约 5229 例高血压患者,其中 2691 例接受了 FCM 治疗,2538 例接受了安慰剂治疗。结论FCM 可减少心房颤动相关的住院治疗,但并不能改善心房颤动和内科疾病患者的总体死亡率或心血管死亡率。总体结果支持 FCM 在控制心衰患者缺铁方面的作用。
{"title":"Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis.","authors":"Burhanuddin Sohail Rangwala, Varisha Zuhair, Muhammad Saqlain Mustafa, Abdullah Mussarat, Aimen Waqar Khan, Fnu Danish, Syeda Mahrukh Fatima Zaidi, Faizan Ur Rehman, Muhammad Ashir Shafique","doi":"10.1080/20565623.2024.2367956","DOIUrl":"10.1080/20565623.2024.2367956","url":null,"abstract":"<p><p><b>Aim:</b> Iron deficiency (ID) is associated with heart failure (HF) in a considerable proportion of patients. To improve the quality of life, lower the frequency of hospitalizations, and lower mortality rates of chronic HF patients (HF), this meta-analysis will look into the role of iron supplementation using ferric carboxymaltose (FCM). <b>Methods & results:</b> From inception until 1 October 2023, we conducted a thorough literature search of electronic databases for peer-reviewed publications. Around 5229 HF patients were included, of which 2691 received FCM while 2538 received placebo. <b>Conclusion:</b> FCM reduces HF-related hospitalizations but doesn't improve overall or cardiovascular mortality in those with HF and ID. The overall results support FCM's role in managing iron deficiency in heart failure.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2367956"},"PeriodicalIF":2.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future Science OA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1